The United States Patent and Trademark Office granted the Aker BioMarine's patent application 15/040,330, which covers Aker’s Flexitech technology, used to make Superba 2 and Superba Boost krill oil products at its Houston facility.
Photo © iStockphoto.com
Aker BioMarine announced that the United States Patent and Trademark Office granted the company’s patent application 15/040,330, which covers Aker’s Flexitech technology, used to make Superba 2 and Superba Boost krill oil products at its Houston facility. Flexitech was developed to improve encapsulation properties such as improved smell, taste, and appearance, by removing trimethylamine N-oxide (TMAO), a salt, from the oil. TMAO converts to trimethylamine (TMA), an organic compound largely responsible for seafood’s “fishy” odor.
This new patent application contains 11 claims that cover the high efficiency process of extracting lipids from krill biomass. “The Flexitech technology does not involve any form of high temperature treatment such as molecular distillation or the use of other solvents besides ethanol and water,” explains Matts Johansen, CEO of Aker BioMarine, in a press release. “It relies solely on low temperature and efficient fractionation methods, which remove unwanted salts and other polar constituents. It has opened the doors to new products such as Superba 2 and Superba Boost.”
The new patent strengthens the company’s existing patent portfolio and future generations of Aker products. “This is a major development for our company and the industry,” adds Johansen. “Aker BioMarine is fully committed to the research and development behind our krill oil products and this patent allows us to continue investing in R&D for years to come.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.